Another study has shown that TET1 and TET2 enzymes have distinct functions in T-ALL development; TET1 acts as an oncogene in T-ALL, while TET2 is tumor suppressing [58]. This evidence concerns the gene TET1 and acute lymphoblastic leukemia.